| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A phase II, randomized, multicenter study evaluating the combination of lapatinib and vinorelbine in women with ErbB2 overexpressing metastatic breast cancer
|
Janni, Wolfgang
|
|
2014
|
143 |
3 |
p. 493-505
|
article
|
| 2 |
Central pathology laboratory review of HER2 and ER in early breast cancer: an ALTTO trial [BIG 2-06/NCCTG N063D (Alliance)] ring study
|
McCullough, Ann E.
|
|
2014
|
143 |
3 |
p. 485-492
|
article
|
| 3 |
Circulating estrogens and estrogens within the breast among postmenopausal BRCA1/2 mutation carriers
|
Loud, Jennifer T.
|
|
2014
|
143 |
3 |
p. 517-529
|
article
|
| 4 |
Clinical significance of CYLD downregulation in breast cancer
|
Hayashi, Mitsuhiro
|
|
2014
|
143 |
3 |
p. 447-457
|
article
|
| 5 |
Clinicopathological significance of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in oestrogen-receptor-positive breast cancer
|
Abdel-Fatah, Tarek M. A.
|
|
2013
|
143 |
3 |
p. 411-421
|
article
|
| 6 |
Context-dependent role of Grb7 in HER2+ve and triple-negative breast cancer cell lines
|
Lim, Reece C. C.
|
|
2014
|
143 |
3 |
p. 593-603
|
article
|
| 7 |
Estrogen receptor status of breast stromal cells
|
Knower, Kevin C.
|
|
2014
|
143 |
3 |
p. 609-610
|
article
|
| 8 |
Everolimus plus exemestane as first-line therapy in HR+, HER2− advanced breast cancer in BOLERO-2
|
Beck, J. Thaddeus
|
|
2013
|
143 |
3 |
p. 459-467
|
article
|
| 9 |
Factors associated with long-term adherence to annual surveillance mammography among breast cancer survivors
|
Wirtz, Heidi S.
|
|
2014
|
143 |
3 |
p. 541-550
|
article
|
| 10 |
Inhibition of FGFR signaling by PD173074 improves antitumor immunity and impairs breast cancer metastasis
|
Ye, Tinghong
|
|
2014
|
143 |
3 |
p. 435-446
|
article
|
| 11 |
Long-term impact of the 70-gene signature on breast cancer outcome
|
Drukker, C. A.
|
|
2014
|
143 |
3 |
p. 587-592
|
article
|
| 12 |
Patterns of nodal staging during breast conservation surgery in the medicare patient: will the ACOSOG Z0011 trial change the pattern of care?
|
Loveland-Jones, Catherine E.
|
|
2014
|
143 |
3 |
p. 571-577
|
article
|
| 13 |
Progesterone stimulates progenitor cells in normal human breast and breast cancer cells
|
Hilton, Heidi N.
|
|
2014
|
143 |
3 |
p. 423-433
|
article
|
| 14 |
Prospective evaluation of the conversion rate in the receptor status between primary breast cancer and metastasis: results from the GEICAM 2009-03 ConvertHER study
|
Dueñas, Eduardo Martínez de
|
|
2014
|
143 |
3 |
p. 507-515
|
article
|
| 15 |
Steroid hormone receptor expression in breast cancer stroma
|
Booth, Mary E.
|
|
2014
|
143 |
3 |
p. 605-607
|
article
|
| 16 |
Tamoxifen dose and serum concentrations of tamoxifen and six of its metabolites in routine clinical outpatient care
|
Jager, N. G. L.
|
|
2014
|
143 |
3 |
p. 477-483
|
article
|
| 17 |
The impact of the pathological lymph node status on adjuvant systemic treatment recommendations in clinically node negative breast cancer patients
|
Roozendaal, L. M. van
|
|
2014
|
143 |
3 |
p. 469-476
|
article
|
| 18 |
Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers
|
Kotsopoulos, Joanne
|
|
2014
|
143 |
3 |
p. 579-586
|
article
|
| 19 |
Treatment and outcomes in diabetic breast cancer patients
|
Gold, Heather Taffet
|
|
2014
|
143 |
3 |
p. 551-570
|
article
|
| 20 |
Utility of 3-dimensional echocardiography, global longitudinal strain, and exercise stress echocardiography to detect cardiac dysfunction in breast cancer patients treated with doxorubicin-containing adjuvant therapy
|
Khouri, Michel G.
|
|
2014
|
143 |
3 |
p. 531-539
|
article
|
Journal description